Novo Nordisk, the maker of Wegovy, will focus on commercial strategy and cost reduction. This decision follows a profit ...

The Federal Reserve's decision to avoid signaling imminent rate cuts despite relentless political pressure underscores its ...

The brokerage attributed the projected EPS growth in FY26 to an expected improvement in the macroeconomic environment, ...

By Bharath Rajeswaran and Vivek Kumar M (Reuters) -Indian shares fell on Wednesday, dragged by rate-sensitive stocks after ...

The NIH plans to cap indirect research grants at 15%, down from the current average of 27%-28%. The cuts could limit students’ access to research programs.

Is this finally the year CRISPR Therapeutics (NASDAQ: CRSP) bounces back? The biotech has lagged the market in recent years, but shares are up 50% over the past three months and have climbed 42% since ...

Wall Street continued to look past tariff uncertainty on Tuesday, with analysts at Bank of America and Goldman Sachs raising ...

Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent ...

Led by a trained professional, you gather at the beach while spotters search for turtles coming ashore to lay their eggs. If ...

We visited four of the country’s “crown jewels” and found deep concern for the park system’s future among Americans of all ...

This move by Trump could further increase oil prices, as countries dependent on Russian crude would face a difficult choice ...

The " Eating the Earth ” column explores the connections between the food we eat and the climate we live in. These days, I’m ...